Quick answers
- What is Emend?
- Emend is a brand name of Aprepitant and Fosaprepitant, a prescription medicine. The FDA NDC Directory lists 5 Emend products in 5 strengths and forms.
- Who makes Emend?
- MSD holds the FDA application for Emend (NDA021549, approved March 26, 2003).
- Is there a generic or store brand of Emend?
- Yes. The FDA NDC Directory lists 37 other products with the same active ingredients, strength and form as a Emend product, 36 of them generic. Ask your pharmacist whether one is right for you.
- What do pharmacies pay for Emend?
- CMS lists a National Average Drug Acquisition Cost (NADAC) for 1 Emend strength and form (see the table below). That is what pharmacies pay to buy it, not what you pay: your price depends on your insurance and your pharmacy.
- Has Emend been recalled?
- FDA enforcement reports list 1 recall of Emend products; the newest started December 12, 2025. A recall usually concerns specific lots, not every product.
What Emend is
Each Emend product as listed in the FDA NDC Directory, by active ingredient, strength and form, with its official label. “Same medicine, other names” counts the other products with exactly the same active ingredients, strength and form (generic versions, store brands and other brands); inactive ingredients can differ.
Aprepitant · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| aprepitant 125 mg capsule (oral) | Emend | 5 products, 5 companies | DailyMed |
| aprepitant 125 mg powder, for suspension (oral) | Emend | None listed | DailyMed |
| aprepitant 40 mg capsule (oral) | Emend | 5 products, 5 companies | DailyMed |
| aprepitant 80 mg capsule (oral) | Emend | 5 products, 5 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Aprepitant →
Fosaprepitant · prescription medicine
| Strength and form | Product names | Same medicine, other names | Label |
|---|---|---|---|
| fosaprepitant dimeglumine 150 mg/5 mL injection, powder, lyophilized, for solution (intravenous) | Emend | 22 products, 17 companies | DailyMed |
Its page lists every product and company, the FDA label’s uses and boxed warning, approvals, shortages and recalls: Fosaprepitant →
FDA approval
- NDA: New Drug Application: how a new (usually brand-name) medicine is approved.
What pharmacies pay (NADAC)
The National Average Drug Acquisition Cost (NADAC) is the average price U.S. retail pharmacies paid to buy one unit of a medicine (one tablet, one mL or one gram), from a monthly survey of pharmacy invoices by the Centers for Medicare & Medicaid Services (CMS). State Medicaid programs use it to pay pharmacies.
This is not the price you pay. What you pay depends on your insurance (copay or coinsurance), your pharmacy and any discounts, and pharmacies also charge for filling a prescription. Ask your pharmacist or your health plan what your price will be.
| Strength and form | Generic or brand | Pharmacies pay |
|---|---|---|
| aprepitant 125 mg powder, for suspension | Brand: Emend | $327.38 per unit |
NADAC list of November 4, 2026; these prices took effect on September 23, 2026. Shown only where a package’s NDC code matches the NADAC list exactly, and only for that exact strength and form: nothing is averaged across strengths. Strengths and forms not listed here have no NADAC price.
Source: NADAC (National Average Drug Acquisition Cost) 2026, data.medicaid.gov (CMS) →
Companies that list Emend
The company named on the package (holder, repackager or distributor), as listed in the FDA NDC Directory, with its number of Emend products.
- Merck Sharp & Dohme LLC5 products
Recalls
From FDA enforcement reports, matched by the product’s NDC code or label. A recall usually covers specific lots: check the lot number on your package and ask your pharmacist. Do not stop a medicine on your own.
-
December 12, 2025 · Class II · Ongoing · D-0241-2026
Presence of particulate matter: potential presence of metal particulates in the product.
Merck Emend (aprepitant) for oral suspension, 125 mg, Single-Dose Kit, Rx Only, Manufactured for: Merck Sharpe & Dohme LLC, Rahway, NJ 07065, USA, Manufactured by: Novo Nordisk Production Ireland Limited Athlone, Ireland — Merck Sharp & Dohme LLC
Sources
- NDC Directory (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drugs@FDA (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug labeling (SPL, openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 30, 2026, retrieved October 31, 2026
- Drug recall enforcement reports (openFDA) — U.S. Food and Drug Administration (FDA), FDA data exported October 27, 2026, retrieved October 31, 2026
- NADAC (National Average Drug Acquisition Cost) 2026 — Centers for Medicare & Medicaid Services (CMS), data.medicaid.gov, list of November 4, 2026, retrieved November 7, 2026
Which names get a brand page: a name the NDC Directory lists for a medicine, held by one company (the FDA application holder, or the company named on most of its products), that is not just a description, and that is not the only product of its medicine.